Valuation: BICO Group AB

Market Cap 1.54B 153M 137M 128M 116M 219M 14.86B 221M 600M 7.55B 576M 564M 24.29B P/E 2026 *
-6.75x
P/E 2027 * -12.2x
Enterprise Value 1.47B 147M 131M 122M 111M 209M 14.2B 211M 573M 7.21B 550M 538M 23.2B EV / Sales 2026 *
0.9x
EV / Sales 2027 * 0.81x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day+2.08%
1 week-1.86%
Current month-1.15%
1 month-3.95%
3 months+56.44%
6 months+12.99%
Current year+4.93%
1 week 1.9
Extreme 1.896
1.98
1 month 1.81
Extreme 1.81
2.01
Current year 1.19
Extreme 1.19
2.04
1 year 1.19
Extreme 1.19
2.25
3 years 1.19
Extreme 1.19
6.35
5 years 1.19
Extreme 1.19
49.34
10 years 1.19
Extreme 1.19
60.8
Manager TitleAgeSince
Chief Executive Officer 51 01/09/2026
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 71 18/12/2019
Director/Board Member 37 01/03/2015
Director/Board Member - 07/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%-1.86% - - 153M
-3.02%-2.01%+19.25%+28.88% 245B
-2.19%+0.74%+4.09%-2.31% 154B
-0.08%+3.36%-7.45%+40.82% 146B
+0.19%-3.63%-56.96%-20.50% 60.26B
-3.43%-2.93%+9.18%+13.44% 49.44B
-2.47%-1.33%+16.80%+47.80% 47.67B
-0.78%+1.73%-21.18%-18.56% 48.04B
+0.23%+0.24%-6.36%+32.57% 45.74B
-2.57%-0.43%+29.32%+58.70% 42.84B
Average -1.20%-1.73%-1.48%+20.09% 93.2B
Weighted average by Cap. -1.81%-2.10%+2.41%+20.88%

Financials

2026 *2027 *
Net sales 1.62B 162M 145M 135M 123M 231M 15.71B 233M 634M 7.98B 609M 596M 25.67B 1.69B 169M 150M 140M 128M 240M 16.32B 242M 659M 8.29B 633M 619M 26.67B
Net income -227M -22.7M -20.27M -18.91M -17.18M -32.32M -2.2B -32.63M -88.79M -1.12B -85.21M -83.36M -3.59B -126M -12.6M -11.25M -10.49M -9.53M -17.94M -1.22B -18.11M -49.28M -620M -47.3M -46.27M -1.99B
Net Debt -69M -6.9M -6.16M -5.75M -5.22M -9.82M -668M -9.92M -26.99M -340M -25.9M -25.34M -1.09B -166M -16.6M -14.82M -13.83M -12.56M -23.63M -1.61B -23.86M -64.93M -817M -62.31M -60.96M -2.63B
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
08/10/26 €1.896 -1.35% 0
07/10/26 €1.922 -2.24% 0
06/10/26 €1.966 -0.51% 0
05/10/26 €1.976 +3.46% 0
02/10/26 €1.910 -1.14% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - BICO Group AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
21.75SEK
Average target price
29.00SEK
Spread / Average Target
+33.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BICO Group AB